Tech Company M&A Transactions
Amira Pharmaceuticals Acquisition
On 7/21/2011, Amira Pharmaceuticals was bought by Bristol-Meyers Squibb. The transaction price was $475 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/21/2011
Transaction Type
M&A
Amount
$475,000,000
M&A Terms
Bristol-Myers Squibb will acquire all of Amira Pharmaceuticals' issued and outstanding shares of capital stock and stock equivalents in an all-cash transaction for a purchase price of $325 million upfront and potential additional milestone payments totaling $150 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9535 Waples St. 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Amira Pharmaceuticals is a privately-held biopharmaceutical company, focused on leveraging the deep expertise of a team of scientists in the field of inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Baltera
Chief Financial Officer
Michael Swanson
Chief Scientific Officer
Peppi Prasit
Vice President
Isabelle DeArmond
Vice President
Jilly Evans
Vice President
John Hutchinson
Browse more venture capital transactions:
Prev: 7/21/2011: Hotlist venture capital transaction
Next: 7/21/2011: Oncoscope venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs